Financial results - OMNAPHARM SRL

Financial Summary - Omnapharm Srl
Unique identification code: 10945397
Registration number: J33/503/1998
Nace: 4773
Sales - Ron
646.197
Net Profit - Ron
54.848
Employees
4
Open Account
Company Omnapharm Srl with Fiscal Code 10945397 recorded a turnover of 2024 of 646.197, with a net profit of 54.848 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Omnapharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 140.789 197.921 265.329 266.764 278.283 372.387 415.374 493.625 573.970 646.197
Total Income - EUR 149.473 206.182 278.556 279.730 296.575 410.272 452.379 544.155 612.913 682.150
Total Expenses - EUR 140.542 188.350 252.511 243.767 277.079 362.300 409.544 503.115 548.203 619.499
Gross Profit/Loss - EUR 8.931 17.832 26.045 35.962 19.497 47.972 42.835 41.040 64.710 62.651
Net Profit/Loss - EUR 7.474 15.319 22.885 33.168 16.636 44.425 39.455 36.820 59.135 54.848
Employees 3 3 4 3 3 3 4 4 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 13.2%, from 573.970 euro in the year 2023, to 646.197 euro in 2024. The Net Profit decreased by -3.957 euro, from 59.135 euro in 2023, to 54.848 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Omnapharm Srl

Rating financiar

Financial Rating -
OMNAPHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Omnapharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Omnapharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Omnapharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Omnapharm Srl - CUI 10945397

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 21.701 26.312 23.597 21.108 38.517 36.160 40.831 40.571 44.072 41.910
Current Assets 54.155 75.453 89.478 101.391 100.011 142.528 163.737 163.491 196.425 246.891
Inventories 26.840 40.452 44.457 52.085 50.211 82.451 90.006 85.452 118.656 136.458
Receivables 17.602 13.254 33.703 41.086 38.153 54.984 60.405 69.897 68.393 75.229
Cash 9.713 21.748 11.318 8.220 11.647 5.093 13.326 8.142 9.375 35.204
Shareholders Funds 38.744 28.791 52.084 62.806 57.345 80.009 97.474 110.263 142.783 163.659
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 37.112 72.975 60.991 59.693 82.172 99.238 107.339 93.799 97.714 125.142
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 246.891 euro in 2024 which includes Inventories of 136.458 euro, Receivables of 75.229 euro and cash availability of 35.204 euro.
The company's Equity was valued at 163.659 euro, while total Liabilities amounted to 125.142 euro. Equity increased by 21.674 euro, from 142.783 euro in 2023, to 163.659 in 2024.

Risk Reports Prices

Reviews - Omnapharm Srl

Comments - Omnapharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.